Alnylam Pharmaceuticals, Inc. (ALNY)

414.94 -0.27 (-0.07%) USD  |  NASDAQ  |  Dec 10, 09:39
More

Alnylam Pharmaceuticals Free Cash Flow Per Share (Quarterly)

Free Cash Flow Per Share (Quarterly) Chart

View Free Cash Flow Per Share (Quarterly) for ALNY.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Free Cash Flow Per Share (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Free Cash Flow Per Share (Quarterly) Range, Past 5 Years

View Free Cash Flow Per Share (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Free Cash Flow Per Share (Quarterly) Benchmarks

View Free Cash Flow Per Share (Quarterly) Benchmarks
Start Trial
Pfizer Inc. Upgrade
Glaukos Corp. Upgrade
Bristol Myers Squibb Co. Upgrade
BridgeBio Pharma, Inc. Upgrade
Vertex Pharmaceuticals, Inc. Upgrade

Free Cash Flow Per Share (Quarterly) Related Metrics

Cash from Operations (Quarterly) Upgrade
Cash from Investing (Quarterly) Upgrade
Cash from Financing (Quarterly) Upgrade
Free Cash Flow Upgrade
Free Cash Flow to Equity (Quarterly) Upgrade
Free Cash Flow to Firm (Quarterly) Upgrade
Free Cash Flow Yield Upgrade